Daniel Brennan
Stock Analyst at TD Cowen
(4.95)
# 216
Out of 5,000 analysts
701
Total ratings
59.9%
Success rate
26.4%
Average return
Main Sectors:
Stocks Rated by Daniel Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRAL GRAIL | Reiterated: Buy | $88 | $125.21 | -29.72% | 8 | Sep 24, 2026 | |
| A Agilent Technologies | Rated: Buy | $155 → $180 | $172.84 | +4.14% | 41 | Aug 27, 2026 | |
| FRNM Freenome | Initiated Coverage: Buy | $17 | $16.01 | +6.18% | 1 | Aug 18, 2026 | |
| MDXH MDxHealth | Reiterated: Buy | $1 | $0.582 | +71.82% | 13 | Aug 13, 2026 | |
| SERA Sera Prognostics | Reiterated: Buy | n/a | $2.10 | - | 16 | Aug 12, 2026 | |
| QTRX Quanterix | Rated: Hold | $4 → $3 | $3.18 | -5.66% | 18 | Aug 11, 2026 | |
| NTRA Natera | Rated: Buy | $325 → $340 | $408.79 | -16.83% | 27 | Aug 7, 2026 | |
| RVTY Revvity | Rated: Buy | $130 | $150.68 | -13.72% | 26 | Aug 7, 2026 | |
| WAT Waters | Upgraded: Buy | $408 → $475 | $430.30 | +10.39% | 29 | Aug 7, 2026 | |
| BDSX Biodesix | Reiterated: Buy | $30 | $29.40 | +2.04% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.58 | +89.87% | 26 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.26 | - | 15 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $10 | $8.74 | +14.42% | 16 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 → $210 | $176.45 | +19.01% | 20 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $192 → $210 | $273.90 | -23.33% | 45 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $28 | $29.57 | -5.31% | 17 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $15 | $15.38 | -2.47% | 26 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $19.56 | -2.86% | 23 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $675 | $678.39 | -0.50% | 40 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $240 → $236 | $223.77 | +5.47% | 33 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $34 | $33.20 | +2.41% | 2 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 → $60 | $64.00 | -6.25% | 26 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $31 → $30 | $32.27 | -7.03% | 9 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $18 | $16.57 | +8.63% | 16 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 → $44 | $44.56 | -1.26% | 26 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $71 | $82.24 | -13.67% | 20 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $47 | $84.11 | -44.12% | 33 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $85 | $88.48 | -3.93% | 20 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9905 | - | 12 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.87 | - | 12 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $4.14 | +69.08% | 21 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $183 | $179.23 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $0.743 | n/a | 11 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 | $101.64 | n/a | 1 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $47.32 | n/a | 1 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 → $62 | $7.65 | n/a | 3 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $184.03 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | - | n/a | 4 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $390 → $465 | $294.44 | n/a | 7 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $880 → $1,139 | $1,519.15 | n/a | 12 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $224 → $275 | $275.02 | n/a | 4 | Apr 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $174 → $232 | $173.90 | n/a | 8 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $48.54 | n/a | 1 | Nov 26, 2013 |
GRAIL
Sep 24, 2026
Reiterated: Buy
Price Target: $88
Current: $125.21
Upside: -29.72%
Agilent Technologies
Aug 27, 2026
Rated: Buy
Price Target: $155 → $180
Current: $172.84
Upside: +4.14%
Freenome
Aug 18, 2026
Initiated Coverage: Buy
Price Target: $17
Current: $16.01
Upside: +6.18%
MDxHealth
Aug 13, 2026
Reiterated: Buy
Price Target: $1
Current: $0.582
Upside: +71.82%
Sera Prognostics
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.10
Upside: -
Quanterix
Aug 11, 2026
Rated: Hold
Price Target: $4 → $3
Current: $3.18
Upside: -5.66%
Natera
Aug 7, 2026
Rated: Buy
Price Target: $325 → $340
Current: $408.79
Upside: -16.83%
Revvity
Aug 7, 2026
Rated: Buy
Price Target: $130
Current: $150.68
Upside: -13.72%
Waters
Aug 7, 2026
Upgraded: Buy
Price Target: $408 → $475
Current: $430.30
Upside: +10.39%
Biodesix
Aug 6, 2026
Reiterated: Buy
Price Target: $30
Current: $29.40
Upside: +2.04%
Aug 6, 2026
Reiterated: Buy
Price Target: $3
Current: $1.58
Upside: +89.87%
Aug 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.26
Upside: -
Aug 4, 2026
Reiterated: Buy
Price Target: $8 → $10
Current: $8.74
Upside: +14.42%
Jul 31, 2026
Rated: Buy
Price Target: $200 → $210
Current: $176.45
Upside: +19.01%
Jul 31, 2026
Rated: Hold
Price Target: $192 → $210
Current: $273.90
Upside: -23.33%
Jul 30, 2026
Rated: Buy
Price Target: $25 → $28
Current: $29.57
Upside: -5.31%
Jul 29, 2026
Reiterated: Hold
Price Target: $11 → $15
Current: $15.38
Upside: -2.47%
Jul 28, 2026
Reiterated: Buy
Price Target: $19
Current: $19.56
Upside: -2.86%
Jul 23, 2026
Reiterated: Buy
Price Target: $675
Current: $678.39
Upside: -0.50%
Jul 22, 2026
Reiterated: Buy
Price Target: $240 → $236
Current: $223.77
Upside: +5.47%
Jul 15, 2026
Reiterated: Buy
Price Target: $30 → $34
Current: $33.20
Upside: +2.41%
Jul 15, 2026
Reiterated: Hold
Price Target: $43 → $60
Current: $64.00
Upside: -6.25%
Jul 15, 2026
Rated: Buy
Price Target: $31 → $30
Current: $32.27
Upside: -7.03%
Jul 15, 2026
Rated: Buy
Price Target: $10 → $18
Current: $16.57
Upside: +8.63%
Jul 15, 2026
Reiterated: Hold
Price Target: $40 → $44
Current: $44.56
Upside: -1.26%
Jul 15, 2026
Reiterated: Buy
Price Target: $68 → $71
Current: $82.24
Upside: -13.67%
Jul 15, 2026
Reiterated: Hold
Price Target: $25 → $47
Current: $84.11
Upside: -44.12%
Jul 15, 2026
Reiterated: Buy
Price Target: $55 → $85
Current: $88.48
Upside: -3.93%
Apr 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.9905
Upside: -
Feb 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.87
Upside: -
Feb 23, 2026
Reiterated: Hold
Price Target: $7
Current: $4.14
Upside: +69.08%
Jul 14, 2025
Reiterated: Hold
Price Target: $183
Current: $179.23
Upside: n/a
May 6, 2025
Reiterated: Buy
Price Target: $2.5
Current: $0.743
Upside: n/a
Apr 27, 2023
Reiterated: Buy
Price Target: $525
Current: $101.64
Upside: n/a
Apr 26, 2023
Reiterated: Buy
Price Target: $45
Current: $47.32
Upside: n/a
Oct 15, 2021
Reiterated: Buy
Price Target: $68 → $62
Current: $7.65
Upside: n/a
Oct 14, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $184.03
Upside: n/a
Oct 14, 2021
Reiterated: Hold
Price Target: n/a
Current: -
Upside: n/a
Aug 17, 2021
Reiterated: Buy
Price Target: $390 → $465
Current: $294.44
Upside: n/a
May 7, 2021
Reiterated: Sell
Price Target: $880 → $1,139
Current: $1,519.15
Upside: n/a
Apr 23, 2021
Reiterated: Buy
Price Target: $224 → $275
Current: $275.02
Upside: n/a
Mar 1, 2021
Upgraded: Buy
Price Target: $174 → $232
Current: $173.90
Upside: n/a
Nov 26, 2013
Initiated Coverage: Buy
Price Target: $16
Current: $48.54
Upside: n/a